Felice Scasso
About
In The Last Decade
Felice Scasso
7 papers receiving 54 citations
Peers
Comparison fields: 5 of 35
- Oncology 19
- Neurology 17
- Sensory Systems 14
- Otorhinolaryngology 13
- Pathology and Forensic Medicine 13
Countries citing papers authored by Felice Scasso
This map shows the geographic impact of Felice Scasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felice Scasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felice Scasso more than expected).
Fields of papers citing papers by Felice Scasso
This network shows the impact of papers produced by Felice Scasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felice Scasso. The network helps show where Felice Scasso may publish in the future.
Co-authorship network of co-authors of Felice Scasso
This figure shows the co-authorship network connecting the top 25 collaborators of Felice Scasso. A scholar is included among the top collaborators of Felice Scasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felice Scasso. Felice Scasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 19 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | [Lymphoma of the Waldeyer's ring: experience at the National Institute for Cancer Research of Genoa]. | 1 |
| 6 | [Sequential or alternate chemo-radiotherapy in the treatment of advanced head and neck tumors. Results of a randomized study]. | 3 |
| 7 | Simultaneous cisplatin and 5-fluorouracil as second-line treatment of head and neck cancer. | 9 |
| 8 | Alteration of chemotherapy (cisplatin and 5-FU) and radiotherapy in the management of advanced or recurrent head and neck cancer: a phase II study. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.